The vaccine bulk manufacturing is scheduled for 2025 with the delivery of the freeze-dried doses set for 2026.

In an emulated target trial, a single dose of modified vaccinia Ankara-Bavarian Nordic vaccine was moderately effective in ...

The WHO’s prequalification assessment was based on data provided by Bavarian Nordic and reviewed by the European Medicines ...

The rate of mpox infection in the vaccinated group was 0.09 for every 1,000 person-days as compared to 0.20 in the ...

Mpox ( formerly known as monkeypox) is a viral infection that can be prevented with just a single dose of an existing vaccine ...

Lessons learned from the COVID pandemic have left the world in a much better position to tackle the current mpox epidemic ...

"This study reinforces the benefit in vaccinating against mpox with MVA-BN and reaffirms that a single dose provides at least ...

The World Health Organization Friday approved MVA-BN as the first mpox vaccine added to its pre-qualification list.

The World Health Organization (WHO) has authorized the MVA-BN vaccine as the first vaccine against mpox to be added to its ...

The African health agency says that Rwanda has started a vaccination campaign against mpox with 1,000 doses it obtained from ...

One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is moderately effective against mpox infection in ...

On September 13, 2024, the World Health Organization (WHO) announced that it added the first vaccine against monkeypox (mpox) to its ...